Summary
- Current Price
- As of today, SYRE price is $39.89, down -1.29% on
- Current Price All-Time High
- SYRE price is currently -87.49% below its historical high of $318.75 set on
- Market Cap
- SYRE current market cap is $3B, up +184.89% over the past 365 days
- PE Ratio
- SYRE PE ratio is unknown
- Revenue
- SYRE current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for SYRE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Spyre Therapeutics, Inc. |
| Ticker | NASDAQ: SYRE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | spyre.com |
| Employees | 73 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $39.89 | |
| Price, 1D Change | -1.29% | |
| $3B | ||
| - | ||
| - | ||
| 1.55 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.98 | ||
| EPS, 1Y Change | +37.88% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AGLE | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.98 | ||
| EPS Estimate | N/A | -$2.85 |
| EPS Est. Change | N/A | -44.11% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $39.89 | |
| Price Target | - | $59.50 |
| Price Tgt. Change | - | +49.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.30 | -$3.18 | +25.97% | |
| -$2.12 | -$1.98 | +6.66% | |
| -$2.85 | N/A | -44.11% | |
| -$3.00 | N/A | -51.93% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.09M | $0.00 | -100.00% | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $39.89 | |
| $24.25 | ||
| SMA 200 vs Price | -39.20% | |
| $35.93 | ||
| SMA 50 vs Price | -9.93% | |
| 1.55 | ||
| $2.25 | ||
| 53.14 | ||
| 38.01% | ||
| 68.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.98 | ||
| $0.00 | ||
| - | ||
| -$219.56M | ||
| - | ||
| -$126.54M | ||
| - | ||
| -$219.56M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 13.25 | ||
| 13.25 | ||
| - | ||
| - | ||
| 27.84 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.53 | ||
| -10.65 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $559.42M | ||
| $756.53M | ||
| $777.78M | ||
| $777.78M | ||
| $62.55M | ||
| $58.69M | ||
| $0.00 | ||
| $0.00 | ||
| $8.90M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $126.54M | ||
| $219.56M | ||
| $0.00 | ||
| $47.91M | ||
| $0.00 | ||
| $0.00 | ||
| -$15.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$169.41M | ||
| -$143.48M | ||
| $309.19M | ||
| $0.00 | ||
| -$169.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| BTIG | → | |
| BTIG | → | |
| Mizuho | ||
| Citigroup | ||
| Jones Trading | → | |
| Deutsche Bank | ||
| BTIG | → | |
| Leerink Partners | ||
| Jones Trading |
Analyst sentiment
Institutional ownership
Screeners with SYRE
FAQ
What is the ticker symbol for Spyre Therapeutics, Inc.?
The ticker symbol for Spyre Therapeutics, Inc. is NASDAQ:SYRE
Does Spyre Therapeutics, Inc. pay dividends?
No, Spyre Therapeutics, Inc. does not pay dividends
What sector is Spyre Therapeutics, Inc. in?
Spyre Therapeutics, Inc. is in the Healthcare sector
What industry is Spyre Therapeutics, Inc. in?
Spyre Therapeutics, Inc. is in the Biotechnology industry
What country is Spyre Therapeutics, Inc. based in?
Spyre Therapeutics, Inc. is headquartered in United States
When did Spyre Therapeutics, Inc. go public?
Spyre Therapeutics, Inc. initial public offering (IPO) was on April 7, 2016
Is Spyre Therapeutics, Inc. in the S&P 500?
No, Spyre Therapeutics, Inc. is not included in the S&P 500 index
Is Spyre Therapeutics, Inc. in the NASDAQ 100?
No, Spyre Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Spyre Therapeutics, Inc. in the Dow Jones?
No, Spyre Therapeutics, Inc. is not included in the Dow Jones index
When was Spyre Therapeutics, Inc. last earnings report?
Spyre Therapeutics, Inc.'s most recent earnings report was on February 19, 2026
When does Spyre Therapeutics, Inc. report earnings?
The next expected earnings date for Spyre Therapeutics, Inc. is May 7, 2026
Data Sources & References
- SYRE Official Website www.spyre.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1636282/000163628226000020/0001636282-26-000020-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1636282/000163628226000020/0001636282-26-000020-index.htm
- SYRE Profile on Yahoo Finance finance.yahoo.com/quote/SYRE
- SYRE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/syre